Russell Investments Group, Ltd.
Position in CADL — Candel Therapeutics, Inc.
CIK 1692234
Seattle, WA
Position in CADL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$18,129
-$5,391 QoQ
Shares Held
3,700
-11.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 96.67567567567568.ToString("F0")%
Shared 0.ToString("F0")%
None 3.3243243243243246.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. CADL ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
228,086 | $176,228,356 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
367,691 | $164,188,731 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,397,958 | $67,060,041 | |
| 4 | INCY |
Incyte Corp
|
638,242 | $60,071,331 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
147,533 | $48,814,236 | |
| 6 | MRNA |
Moderna, Inc.
|
710,640 | $36,100,509 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
606,224 | $34,245,589 | |
| 8 | INSM |
INSMED Inc
|
169,162 | $27,661,365 |
All Filings in CADL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,129 | 3,700 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $23,520 | 4,163 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,615 | 3,258 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $26,735 | 4,732 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $32,576 | 3,753 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $14,850 | 2,143 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||